ROCKWELL MEDICAL, INC. Notes Assumed
ROCKWELL MEDICAL, INC. (RMTI) reported Notes Assumed of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:NotesAssumed1 · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. notes assumed for the quarter ending 2025-12-31 was $0.00.
- ROCKWELL MEDICAL, INC. notes assumed for the quarter ending 2025-09-30 was $0.00.
- ROCKWELL MEDICAL, INC. notes assumed for the quarter ending 2024-12-31 was $0.00.
- ROCKWELL MEDICAL, INC. notes assumed for the quarter ending 2024-09-30 was $0.00.
- ROCKWELL MEDICAL, INC. notes assumed for fiscal 2025 was $660.00K, a 1.49% decline from fiscal 2024.
- ROCKWELL MEDICAL, INC. notes assumed for fiscal 2024 was $670.00K, a 8.59% decline from fiscal 2023.
- ROCKWELL MEDICAL, INC. notes assumed for fiscal 2023 was $733.00K, a 45.73% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. notes assumed for fiscal 2022 was $503.00K.
| Period end | Notes Assumed 3 month | Notes Assumed 6 month | Notes Assumed 9 month | Notes Assumed 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $660.00K 10-K · filed 2026-03-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $660.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $660.00K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $670.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $670.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $670.00K 10-Q · filed 2025-08-14 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $733.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $733.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $733.00K 10-Q · filed 2024-08-08 | |||
| 2022-12-31 | $503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $503.00K derived: sum of 2 quarters · filed 2024-03-21 | $503.00K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | |||
| 2019-09-30 | -$763.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.15M 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $1.91M 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |